Zdrowie i gospodarka · 19/09/2016

FDA Releases Draft Guidance on Nonclinical Evaluation for Anticancer Pharmaceuticals

The FDA has released a draft guidance, S9 Nonclinical Evaluation for Anticancer Pharmaceuticals--Questions and Answers, which provides recommendations for nonclinical studies for the development of anticancer pharmaceuticals, developed under the International Council for Harmonisation (ICH).